Acid
Control...
faster
Pantoprazole in Panspane-40 Injection is FDA-labeled for short course treatment of GERD as an alternative to oral therapy. It can heal severe erosive esophagitis, reduce rebleeding in bleeding peptic ulcer, and treat pathological hypersecretory conditions associated with neoplasia such as ZES.
Brings
Relief - Safely
This medication has been labeled by the FDA as a short-course treatment for GERD, providing an alternative to oral therapy. Panspane-40 Injection has been proven to heal severe erosive esophagitis and is effective in reducing rebleeding in cases of bleeding peptic ulcer. Additionally, it has been found useful in the treatment of pathological hypersecretory conditions associated with neoplasia, such as ZES.
- FDA labeled short course treatment of GERD as an alternative to oral therapy (1)
- Heals severe erosive Esophagitis (2)
- Reduces rebleeding effectively in bleeding peptic ulcer (3)
- Useful in the treatment of pathological hypersecretory conditions associated with neoplasia such as ZES
1. American Product Monograph Rev 09/05 | 2. Dig Dis Sci 2008 June; 53(6): 1500-5 | 3. Digestion 2008;78(1):39-43
In Erosive Esophagitis, Peptic ulcer,
Post operative Suppression of acid
- Steady levels from first dose.
- Excellent for tonsillopharyngitis treatment.
- Oral option matching injectable efficacy.
